| Product | Description | Monography name* / Chemical name |
| Kolliphor® EL | Solubilizer e.g. for microneedles, approved for injectable formulations. | Ph.Eur.: Macrogolglycerol ricinoleate, USP / NF: Polyoxyl 35 castor oil |
| Kolliphor® HS 15 | Solubilizer e.g. for microneedles, approved for injectable formulations. | Ph. Eur., USP / NF: Polyethylene glycol-15-hydroxystearate |
| Kolliphor® P 188 | Inert, biocompatible, amphiphilic polymer, approved for injectable applications. | Ph. Eur., USP / NF, JP: Poloxamer |
| Kollidon® 12 PF | Pyrogen free; approved for injectables; Suitable for dissolvable microneedles. | Ph. Eur., USP / NF, FCC: Polyvinylpyrrolidone, Povidon |
| Kollidon® 17 PF | Pyrogen free; approved for injectables; Suitable for dissolvable microneedles. | Ph. Eur., USP / NF, JP, FCC: Polyvinylpyrrolidone, Povidone |
| Kollidon® CL-M | For drug solubilization and transdermal drug delivery aid. | Ph. Eur., USP / NF, JPE, FCC: Crospovidone, cross linked polyvinylpyrroli done |
| Kollidon® 25 | Drug solubilizer. | Ph. Eur., USP / NF, JP, FCC: Polyvinylpyrrolidone, Povidone |
| Kollidon® 30 & 30 LP | Drug solubilizer with low peroxide option. | Ph. Eur., USP / NF, JP, FCC: Polyvinylpyrrolidone, Povidone |
| Kollidon® 90 F | Drug solubilizer and delivery aid in transdermal patches. | Ph. Eur., USP / NF, JP, FCC: Polyvinylpyrrolidone, Povidone |
| Soluplus® | Forms solid solutions, increasing solubility & bioavailability. Extrudable into films | Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer |
| Kollidon® VA 64 | Drug solubilizer & matrix former in extruded or solvent cast films. | Ph. Eur., USP / NF, JPE: Copovidone, Vinylpyrrolidone / vinyl acetate copolymer |





